T1	Participants 250 291	stage III (regional lymph nodes) melanoma
T2	Participants 293 362	After lymph node excision, patients without any detectable metastases
T3	Participants 547 568	Eighty-eight patients
T4	Participants 1371 1421	reatment was compatible with normal daily activity
